Caring for the Critically Ill Patient
Claudia S. Robertson, MD; H. Julia Hannay, PhD; José-Miguel Yamal, PhD; et al.
free access
has audio
JAMA. 2014;312(1):36-47. doi:10.1001/jama.2014.6490
Robertson and coauthors and the Epo Severe TBI Trial Investigators report the results of a randomized clinical trial on the effect of erythropoietin administration and transfusion threshold on neurological recovery after traumatic brain injury.
-
Podcast:
of Effect of Erythropoietin and Transfusion Threshold on Neurological Recovery After Traumatic Brain Injury: A Randomized Clinical Trial
Matthew M. Hsieh, MD; Courtney D. Fitzhugh, MD; R. Patrick Weitzel, PhD; et al.
free access
has multimedia
has audio
JAMA. 2014;312(1):48-56. doi:10.1001/jama.2014.7192
In a trial involving 30 adult patients with sickle cell phenotype with or without thalassemia, Hsieh and coauthors report that after undergoing nonmyeloablative allogeneic hematopoietic stem cell transplantation from human leukocyte antigen–matched siblings, 26 patients achieved long-term engraftment.
-
Podcast:
Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype
Andrew X. Zhu, MD, PhD; Masatoshi Kudo, MD, PhD; Eric Assenat, MD, PhD; et al.
free access
JAMA. 2014;312(1):57-67. doi:10.1001/jama.2014.7189
With the first Everolimus for Liver Cancer Evaluation (EVOLVE-1) study, Zhu and coauthors investigated the efficacy of everolimus in patients with advanced hepatocellular carcinoma for whom sorafenib treatment failed. This randomized, double-blind, phase 3 study was conducted among 546 adults with Barcelona Clinic Liver Cancer stage B or C hepatocellular carcinoma and Child-Pugh A liver function.
Robert W. Taylor, PhD, FRCPath; Angela Pyle, PhD; Helen Griffin, PhD; et al.
free access
JAMA. 2014;312(1):68-77. doi:10.1001/jama.2014.7184
To determine the molecular basis of multiple respiratory chain complex deficiencies, Taylor and coauthors used a whole-exome sequencing approach in 53 patients with biochemical evidence of multiple respiratory chain complex defects but no primary pathogenic mitochondrial DNA mutation.